Civic Intelligence

Watching Over Mothers & Babies Foundation

990EZ • Fiscal year 2020 • EIN 52-2420995

Jul 01, 2019 to Jun 30, 2020 • Filed on May 09, 2021

5245 E Knight DriveTucson, AZ 85712

(520) 882-9662

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

63rd percentile

0.01x

Higher debt load relative to assets than 63% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Liabilities / Revenue

64th percentile

0.01x

Higher debt load relative to revenue than 64% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Net Margin

21st percentile

-22%

Higher net margin than 21% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Asset Growth

25th percentile

-13%

Faster asset growth than 25% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Revenue Growth

90th percentile

65%

Faster revenue growth than 90% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Assets

Down

$169,522

Down $24,901 (-13%) from 2019

Net Assets

Down

$167,045

Down $25,126 (-13%) from 2019

Liabilities

Up

$2,477

Up $225 (+10.0%) from 2019

Revenue

Up

$166,207

Up $65,657 (+65%) from 2019

Expenses

Down

$202,167

Down $1,168 (-0.6%) from 2019

Net Income

Up

-$35,960

Up $66,825 (+65%) from 2019

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$600K$400K$200K$0Assets 2013: $467,334Liabilities 2013: $4,093Net Assets 2013: $463,2412013Assets 2014: $460,445Liabilities 2014: $3,368Net Assets 2014: $457,0772014Assets 2015: $369,904Liabilities 2015: $3,393Net Assets 2015: $366,5112015Assets 2016: $287,914Liabilities 2016: $49Net Assets 2016: $287,8652016Assets 2017: $251,143Liabilities 2017: $0Net Assets 2017: $251,1432017Assets 2018: $295,729Liabilities 2018: $0Net Assets 2018: $295,7292018Assets 2019: $194,423Liabilities 2019: $2,252Net Assets 2019: $192,1712019Assets 2020: $169,522Liabilities 2020: $2,477Net Assets 2020: $167,0452020Assets 2021: $118,414Liabilities 2021: $5,540Net Assets 2021: $112,8742021Assets 2022: $209,715Liabilities 2022: $4,205Net Assets 2022: $205,5102022Assets 2023: $265,579Liabilities 2023: $1,865Net Assets 2023: $263,7142023Assets 2024: $177,956Liabilities 2024: $729Net Assets 2024: $177,2272024

Highlighted filing

2020

Assets$169,522
Liabilities$2,477
Net Assets$167,045

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$300K$200K$100K$0-$100K-$200KRevenue 2013: $11,893Expenses 2013: $16,813Net Income 2013: -$4,9202013Revenue 2014: $288,715Expenses 2014: $271,293Net Income 2014: $17,4222014Revenue 2015: $180,831Expenses 2015: $271,397Net Income 2015: -$90,5662015Revenue 2016: $171,357Expenses 2016: $250,003Net Income 2016: -$78,6462016Revenue 2017: $202,169Expenses 2017: $237,742Net Income 2017: -$35,5732017Revenue 2018: $283,486Expenses 2018: $238,935Net Income 2018: $44,5512018Revenue 2019: $100,550Expenses 2019: $203,335Net Income 2019: -$102,7852019Revenue 2020: $166,207Expenses 2020: $202,167Net Income 2020: -$35,9602020Revenue 2021: $138,601Expenses 2021: $193,642Net Income 2021: -$55,0412021Revenue 2022: $290,086Expenses 2022: $197,450Net Income 2022: $92,6362022Revenue 2023: $128,509Expenses 2023: $187,254Net Income 2023: -$58,7452023Revenue 2024: $68,014Expenses 2024: $157,058Net Income 2024: -$89,0442024

Highlighted filing

2020

Revenue$166,207
Expenses$202,167
Net Income-$35,960
Jump To
Filing Snapshot
Filing Period
Jul 1, 2019 to Jun 30, 2020
Signed
May 9, 2021
Return Version
2019v5.2
Gross Receipts
$166,207
Mission and Program Overview

Mission

The Watching Over Mothers & Babies Foundation (WOMB) is partnering with local and national organizations to address a broad array of health problems that continue to impact women and their children.

The watching over mothers & babies foundation (womb) helps mothers with perinatal health problems and is partnering with local and national organizations to address a broad array of perinatal health problems.

Program Services

DescriptionGrantsExpenses
THE WATCHING OVER MOTHERS & BABIES (WOMB) FOUNDATION CONDUCTS RESEARCH IN PARTNERSHIP TO IMPROVE THE HEALTH AND OPTIONS FOR PREGNANT WOMEN AND CHILDREN. THESE EFFORTS SERVE TO OFFER BETTER TREATMENTS FOR PREGNANT WOMEN AND CHILDREN IN THE PURSUIT OF IMPROVING PERINATAL & NEONATAL OUTCOMES. HISTORICALLY WOMB WAS ENGAGED IN A COMBINATION OF INNOVATIVE RESEARCH DEVOTED TO THE TREATMENT OF TOBACCO USE IN PREGNANCY IN AN EFFORT TO INCREASE CESSATION RATES AMONG PREGNANT WOMEN. WHILE THAT GOAL REMAINS, WOMB HAS DIVERSIFIED AND IS COMMITTED TO ADDRESSING OTHER IMPORTANT HEALTH INITIATIVES MOST RECENTLY WOMB HAS APPLIED FOR RESEARCH FUNDING TO APPLY SEVERAL OF THE SAME PRINCIPLES TO OPIOID DEPENDENCE DISORDER IN AN EFFORT TO BETTER MANAGE OPIOID USE IN PREGNANCY.WOMB IS STILL EVALUATING ITS SUCCESS WITH MOTIVATIONAL COUNSELING DIRECTED AT THE PREGNANT WOMEN AND HER PARTNER TO ASSIST IN THE SMOKING CESSATION. THIS PROJECT IS CALLED "FAMILY ALLIANCE AND ITS USE OF MOTIVATIONAL COUNSELING IS BEING COMPARED TO THE STANDARD PRESCRIPTIVE TECHNIQUES MORE COMMONLY USED IN CLINICAL PRACTICE. THE ARIZONA DISEASE CONTROL RESEARCH COMMISSION, NOW CALLED THE ARIZONA BIOMEDICAL RESEARCH COMMISSION PROVIDED THE EARLY FUNDING FOR THIS TRIAL. IN THE EARLY PHASE OF THIS STUDY, DR. MILLER WAS STILL FULL-TIME FACULTY AT THE UNIVERSITY OF ARIZONA, HOWEVER UPON LEAVING HIS POSITION, HE DESIRED TO CONTINUE THIS WORK THROUGH THE CREATION OF THE WOMB FOUNDATION WHICH HAS CONTINUED TO SUPPORT IT OVER THE YEARS.WOMB IS COMPLETING ITS DATA ANALYSIS AND WILL BE PUBLISHING THE RESULTS OF A NIH FUNDED PILOT RCT UTILIZING BUPROPION AS A CESSATION AIDE IN CONJUNCTION WITH COUNSELING. WOMB HAS ALSO STARTED THE PROCESS OF EXPLORING OTHER INITIATIVES IN THE CONCERTED GOAL OF REDUCING TOBACCO USE IN PREGNANCY, BOTH PRIMARY AND SECONDARY.IN THE PAST SEVERAL YEARS WOMB HAS BEEN INVOLVED IN RESEARCH FOCUSED ON REDUCING THE RISK OF RSV BY IMMUNIZING PREGNANT WOMEN AND CONVEYING PASSIVE IMMUNITY AS WE DO WITH SEVERAL OTHER VIRAL INFECTIONS SUCH AS INFLUENZA AND PERTUSSIS. THE GOAL OF SIGNIFICANTLY REDUCING RSV BRIDGES THE MATERNAL-NEONATAL FIELDS WHICH HISTORICALLY HAS BEEN DIFFICULT TO DO.OTHER ACTIVE RESEARCH ACTIVITIES INCLUDE:1. COOK STUDY: RCT COMPARING THE CRB WITH PITOCIN TO PITOCIN ALONE IN PREMATURE RUPTURE OF MEMBRANES (PROM) PATIENTS WITH AN UNFAVORABLE CERVIX WAS COMPLETED THIS YEAR AND DATA ANALYSIS IS ONGOING. WE EXPECT TO PRESENT THE RESULTS AT THE ANNUAL SMFM MEETING IN 2021.2. ACTIM PARTUS TEST: IS A STUDY DESIGNED TO EVALUATE A NEW DIAGNOSTIC TECHNOLOGY TO DETECT PRETERM LABOR AT AN EARLY STAGE WHERE IT MIGHT BE TREATED AVOIDING THE SERIOUS CONSEQUENCES OF A PRETERM BIRTH (PTB). THIS STUDY WAS ALSO COMPLETED AND IS UNDER REVIEW BY THE FDA.3. NOVAVAX HAS BEEN WORKING WITH THE WHO/GATES FOUNDATION TO DEVELOP A RSV VACCINE: A PHASE 3, RANDOMIZED, OBSERVER-BLIND, PLACEBO-CONTROLLED, GROUP-SEQUENTIAL STUDY TO DETERMINE THE IMMUNOGENICITY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) F NANOPARTICLE VACCINE WITH ALUMINUM IN HEALTHY THIRD-TRIMESTER PREGNANT WOMEN; AND SAFETY AND EFFICACY OF MATERNALLY TRANSFERRED ANTIBODIES IN PREVENTING RSV DISEASE IN THEIR INFANTS. STUDY ENROLLMENT WAS ALSO COMPLETED THIS YEAR, BUT LONG-TERM OUTCOMES ARE STILL BEING COLLECTED.4. PFIZER HAS BEEN DEVELOPING ITS OWN RSV VACCINE AND LAUNCHED AN RCT IN 2018. A PHASE 2B RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PERFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY.5. WOMB PLACES A PREMIUM ON BREAST FEEDING AND SUPPORTING WOMEN IN THAT GOAL BUT WE ALSO RECOGNIZE FOR A VARIETY OF REASONS THERE IS A SIGNIFICANT NUMBER OF WOMEN WHO ARE UNABLE OR UNWILLING TO BREAST FEED. THEIR CHILDREN DESERVE THE BEST NUTRITIONAL OPTION AND THOSE CHOICES CAN ONLY BE DETERMINED WITH ONGOING RESEARCH IN THIS AREA. WOMB CONTINUES TO PARTICIPATE IN SEVERAL ABBOTT FORMULA STUDIES DESIGNED TO IMPROVE THE NUTRITIONAL CHARACTERISTICS OF THEIR FORMULAS FOR SPECIFIC NEONATAL POPULATIONS. THE STUDIES ARE DESIGNED TO TEST NEW MILK-BASED FORMULAS FORTIFIED WITH SPECIFIC SUPPLEMENTS TO MEET SPECIFIC NEEDS OF TERM AND PRETERM INFANTS FOR WHOM BREAST FEEDING IS NOT AN OPTION. THE STUDY IS LOOKING AT MULTIPLE MARKERS FOR NUTRITION, GI TOLERATION AND GROWTH.6. COMMON SENSE HAS DEVELOPED AN INNOVATIVE APPROACH TO DIAGNOSE PRETERM RUPTURE OF MEMBRANES THAT MIGHT ULTIMATELY PERMIT MANY WOMEN TO BETTER EVALUATE THEIR STATUS PRIOR TO PRESENTING TO THE HOSPITAL. THE PURPOSE OF THIS STUDY WAS TO COMPARE THIS NEW TECHNOLOGY WITH THE CURRENT STANDARD OF CARE. THIS STUDY HAS BEEN CONCLUDED AND THE RESULTS ARE UNDER REVIEW BY THE FDA.7. WOMB WAS ONE OF THE USA SITES THAT PARTICIPATED IN THE PROLONG TRIAL. USA ENROLLMENT WAS SUSPENDED SEVERAL YEARS AGO BUT THE INTERNATIONAL ENROLLMENT WAS COMPLETED IN 2018, AND THE STUDY RESULTS WERE ANALYZED AND PUBLISHED JUST PRIOR TO THEIR PRESENTATION TO THE FDA IN OCTOBER 2019.$0$174,796
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
DR HUGH MILLERPresident/CEOPT$0--
MICHAEL BROWNCOO/CounselPT$0--
DR MONICA CASPERSecretary/Treasurer-$0--
KENNETH RAMOSMember-$0--
RALPH FREGOSIMember-$0--
PENNY BUSSEL-STANSFIELDMember-$0--
Filing and Contact Details

Filer

Filer Name
Watching Over Mothers & Babies
EIN
52-2420995
Phone
5208829662
Address
5245 E KNIGHT DRIVE, TUCSON, AZ 85712

Signing Officer

Name
Dr Hugh Miller
Title
CEO
Phone
5208829662
Signed
2021-05-09
Discuss with paid preparer
Yes

Preparer

Firm
Hbl Cpas Pc
Address
5470 E BROADWAY BLVD, TUCSON, AZ 85711
Preparer
Michael J Devries
Phone
5208863181
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16 - Other Expenses

Description: insurance. Amount: 5,699. Description: meals & entertainment. Amount: 314. Description: office expenses. Amount: 5,941. Description: research studies. Amount: 19,767. Description: depreciation. Amount: 1,477. Total to form 990-ez, line 16: 33,198.

Form 990-ez, Part I, Line 20 - Other Changes in Net Assets

Description: prior period adjustments. Amount: 10,834.

Form 990-ez, Part II, Line 24 - Other Assets

Description: other depreciable assets. Beg. Of year amount: 3,249. End of year amount: 1,772.

Form 990-ez, Part II, Line 26 - Other Liabilities

Description: accounts payable and accrued expenses. Beg. Of year amount: 50. End of year amount: 450. Description: credit cards payable. Beg. Of year amount: 430. End of year amount: 255. Description: payroll taxes payable. Beg. Of year amount: 1,772. End of year amount: 1,772.

Raw XML Appendix144 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd00
IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0THE ORGANIZATION
IRS990EZ/BooksInCareOfDetail/PhoneNum05208829662
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt05245 E KNIGHT DRIVE
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0TUCSON
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0AZ
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd085712
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt0191174
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0167750
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd00
IRS990EZ/DirectIndirectPltclExpendAmt00
IRS990EZ/DonorAdvisedFndsInd00
IRS990EZ/EngagedInExcessBenefitTransInd00
IRS990EZ/ExcessOrDeficitForYearAmt0-35960
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt013830
IRS990EZ/FiledScheduleAInd01
IRS990EZ/ForeignFinancialAccountInd00
IRS990EZ/ForeignOfficeInd00
IRS990EZ/Form990TotalAssetsGrp/BOYAmt0194423
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0169522
IRS990EZ/GrossReceiptsAmt0166207
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/LobbyingActivitiesInd00
IRS990EZ/MadeLoansToFromOfficersInd00
IRS990EZ/MethodOfAccountingAccrualInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt0192171
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0167045
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt0192171
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0167045
IRS990EZ/OccupancyRentUtltsAndMaintAmt027328
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt030.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt120.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt20.20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt30.20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt40.20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt50.20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/EmployeeBenefitProgramAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/ExpenseAccountOtherAllwncAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0DR HUGH MILLER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1MICHAEL BROWN
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2DR MONICA CASPER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3KENNETH RAMOS
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4RALPH FREGOSI
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5PENNY BUSSEL-STANSFIELD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT/CEO
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1COO/COUNSEL
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2SECRETARY/TREASURER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4MEMBER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5MEMBER
IRS990EZ/OperateHospitalInd00
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd00
IRS990EZ/OrganizationHadUBIInd00
IRS990EZ/OtherAssetsTotalDetail/BOYAmt03249
IRS990EZ/OtherAssetsTotalDetail/EOYAmt01772
IRS990EZ/OtherChangesInNetAssetsAmt010834
IRS990EZ/OtherExpensesTotalAmt033198
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd00
IRS990EZ/PrimaryExemptPurposeTxt0THE WATCHING OVER MOTHERS & BABIES FOUNDATION (WOMB) HELPS MOTHERS WITH PERINATAL HEALTH PROBLEMS AND IS PARTNERING WITH LOCAL AND NATIONAL ORGANIZATIONS TO ADDRESS A BROAD ARRAY OF PERINATAL HEALTH PROBLEMS.
IRS990EZ/PrintingPublicationsPostageAmt0878
IRS990EZ/ProgramServiceRevenueAmt0166207
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0THE WATCHING OVER MOTHERS & BABIES (WOMB) FOUNDATION CONDUCTS RESEARCH IN PARTNERSHIP TO IMPROVE THE HEALTH AND OPTIONS FOR PREGNANT WOMEN AND CHILDREN. THESE EFFORTS SERVE TO OFFER BETTER TREATMENTS FOR PREGNANT WOMEN AND CHILDREN IN THE PURSUIT OF IMPROVING PERINATAL & NEONATAL OUTCOMES. HISTORICALLY WOMB WAS ENGAGED IN A COMBINATION OF INNOVATIVE RESEARCH DEVOTED TO THE TREATMENT OF TOBACCO USE IN PREGNANCY IN AN EFFORT TO INCREASE CESSATION RATES AMONG PREGNANT WOMEN. WHILE THAT GOAL REMAINS, WOMB HAS DIVERSIFIED AND IS COMMITTED TO ADDRESSING OTHER IMPORTANT HEALTH INITIATIVES MOST RECENTLY WOMB HAS APPLIED FOR RESEARCH FUNDING TO APPLY SEVERAL OF THE SAME PRINCIPLES TO OPIOID DEPENDENCE DISORDER IN AN EFFORT TO BETTER MANAGE OPIOID USE IN PREGNANCY.WOMB IS STILL EVALUATING ITS SUCCESS WITH MOTIVATIONAL COUNSELING DIRECTED AT THE PREGNANT WOMEN AND HER PARTNER TO ASSIST IN THE SMOKING CESSATION. THIS PROJECT IS CALLED "FAMILY ALLIANCE AND ITS USE OF MOTIVATIONAL COUNSELING IS BEING COMPARED TO THE STANDARD PRESCRIPTIVE TECHNIQUES MORE COMMONLY USED IN CLINICAL PRACTICE. THE ARIZONA DISEASE CONTROL RESEARCH COMMISSION, NOW CALLED THE ARIZONA BIOMEDICAL RESEARCH COMMISSION PROVIDED THE EARLY FUNDING FOR THIS TRIAL. IN THE EARLY PHASE OF THIS STUDY, DR. MILLER WAS STILL FULL-TIME FACULTY AT THE UNIVERSITY OF ARIZONA, HOWEVER UPON LEAVING HIS POSITION, HE DESIRED TO CONTINUE THIS WORK THROUGH THE CREATION OF THE WOMB FOUNDATION WHICH HAS CONTINUED TO SUPPORT IT OVER THE YEARS.WOMB IS COMPLETING ITS DATA ANALYSIS AND WILL BE PUBLISHING THE RESULTS OF A NIH FUNDED PILOT RCT UTILIZING BUPROPION AS A CESSATION AIDE IN CONJUNCTION WITH COUNSELING. WOMB HAS ALSO STARTED THE PROCESS OF EXPLORING OTHER INITIATIVES IN THE CONCERTED GOAL OF REDUCING TOBACCO USE IN PREGNANCY, BOTH PRIMARY AND SECONDARY.IN THE PAST SEVERAL YEARS WOMB HAS BEEN INVOLVED IN RESEARCH FOCUSED ON REDUCING THE RISK OF RSV BY IMMUNIZING PREGNANT WOMEN AND CONVEYING PASSIVE IMMUNITY AS WE DO WITH SEVERAL OTHER VIRAL INFECTIONS SUCH AS INFLUENZA AND PERTUSSIS. THE GOAL OF SIGNIFICANTLY REDUCING RSV BRIDGES THE MATERNAL-NEONATAL FIELDS WHICH HISTORICALLY HAS BEEN DIFFICULT TO DO.OTHER ACTIVE RESEARCH ACTIVITIES INCLUDE:1. COOK STUDY: RCT COMPARING THE CRB WITH PITOCIN TO PITOCIN ALONE IN PREMATURE RUPTURE OF MEMBRANES (PROM) PATIENTS WITH AN UNFAVORABLE CERVIX WAS COMPLETED THIS YEAR AND DATA ANALYSIS IS ONGOING. WE EXPECT TO PRESENT THE RESULTS AT THE ANNUAL SMFM MEETING IN 2021.2. ACTIM PARTUS TEST: IS A STUDY DESIGNED TO EVALUATE A NEW DIAGNOSTIC TECHNOLOGY TO DETECT PRETERM LABOR AT AN EARLY STAGE WHERE IT MIGHT BE TREATED AVOIDING THE SERIOUS CONSEQUENCES OF A PRETERM BIRTH (PTB). THIS STUDY WAS ALSO COMPLETED AND IS UNDER REVIEW BY THE FDA.3. NOVAVAX HAS BEEN WORKING WITH THE WHO/GATES FOUNDATION TO DEVELOP A RSV VACCINE: A PHASE 3, RANDOMIZED, OBSERVER-BLIND, PLACEBO-CONTROLLED, GROUP-SEQUENTIAL STUDY TO DETERMINE THE IMMUNOGENICITY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) F NANOPARTICLE VACCINE WITH ALUMINUM IN HEALTHY THIRD-TRIMESTER PREGNANT WOMEN; AND SAFETY AND EFFICACY OF MATERNALLY TRANSFERRED ANTIBODIES IN PREVENTING RSV DISEASE IN THEIR INFANTS. STUDY ENROLLMENT WAS ALSO COMPLETED THIS YEAR, BUT LONG-TERM OUTCOMES ARE STILL BEING COLLECTED.4. PFIZER HAS BEEN DEVELOPING ITS OWN RSV VACCINE AND LAUNCHED AN RCT IN 2018. A PHASE 2B RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) PERFUSION F SUBUNIT VACCINE IN INFANTS BORN TO WOMEN VACCINATED DURING PREGNANCY.5. WOMB PLACES A PREMIUM ON BREAST FEEDING AND SUPPORTING WOMEN IN THAT GOAL BUT WE ALSO RECOGNIZE FOR A VARIETY OF REASONS THERE IS A SIGNIFICANT NUMBER OF WOMEN WHO ARE UNABLE OR UNWILLING TO BREAST FEED. THEIR CHILDREN DESERVE THE BEST NUTRITIONAL OPTION AND THOSE CHOICES CAN ONLY BE DETERMINED WITH ONGOING RESEARCH IN THIS AREA. WOMB CONTINUES TO PARTICIPATE IN SEVERAL ABBOTT FORMULA STUDIES DESIGNED TO IMPR
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt00
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt0174796
IRS990EZ/ProhibitedTaxShelterTransInd00
IRS990EZ/RelatedOrganizationCtrlEntInd00
IRS990EZ/SalariesOtherCompEmplBnftAmt0126933
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd00
IRS990EZ/SubjectToProxyTaxInd00
IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt02252
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt02477
IRS990EZ/TanningServicesProvidedInd00
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt0202167
IRS990EZ/TotalProgramServiceExpensesAmt0174796
IRS990EZ/TotalRevenueAmt0166207
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0WWW.WOMB.ORG
IRS990ScheduleA/HospitalNameAndAddressGrp/CityNm0TUCSON
IRS990ScheduleA/HospitalNameAndAddressGrp/StateAbbreviationCd0AZ
IRS990ScheduleA/HospitalNameAndAddressGrp/SupportedOrganizationName/BusinessNameLine1Txt0TUCSON MEDICAL CENTER
IRS990ScheduleA/MedicalResearchOrganizationInd0X
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0DESCRIPTION: INSURANCE. AMOUNT: 5,699. DESCRIPTION: MEALS & ENTERTAINMENT. AMOUNT: 314. DESCRIPTION: OFFICE EXPENSES. AMOUNT: 5,941. DESCRIPTION: RESEARCH STUDIES. AMOUNT: 19,767. DESCRIPTION: DEPRECIATION. AMOUNT: 1,477. TOTAL TO FORM 990-EZ, LINE 16: 33,198.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1DESCRIPTION: PRIOR PERIOD ADJUSTMENTS. AMOUNT: 10,834.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2DESCRIPTION: OTHER DEPRECIABLE ASSETS. BEG. OF YEAR AMOUNT: 3,249. END OF YEAR AMOUNT: 1,772.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3DESCRIPTION: ACCOUNTS PAYABLE AND ACCRUED EXPENSES. BEG. OF YEAR AMOUNT: 50. END OF YEAR AMOUNT: 450. DESCRIPTION: CREDIT CARDS PAYABLE. BEG. OF YEAR AMOUNT: 430. END OF YEAR AMOUNT: 255. DESCRIPTION: PAYROLL TAXES PAYABLE. BEG. OF YEAR AMOUNT: 1,772. END OF YEAR AMOUNT: 1,772.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16 - OTHER EXPENSES
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART I, LINE 20 - OTHER CHANGES IN NET ASSETS
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART II, LINE 24 - OTHER ASSETS
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART II, LINE 26 - OTHER LIABILITIES
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0DR HUGH MILLER
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0CEO
ReturnHeader/BusinessOfficerGrp/PhoneNum05208829662
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-05-09
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0WATCHING OVER MOTHERS & BABIES
ReturnHeader/Filer/BusinessNameControlTxt0WATC
ReturnHeader/Filer/EIN0522420995
ReturnHeader/Filer/PhoneNum05208829662
ReturnHeader/Filer/USAddress/AddressLine1Txt05245 E KNIGHT DRIVE
ReturnHeader/Filer/USAddress/CityNm0TUCSON
ReturnHeader/Filer/USAddress/StateAbbreviationCd0AZ
ReturnHeader/Filer/USAddress/ZIPCd085712
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0860360084
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0HBL CPAS PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt05470 E BROADWAY BLVD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0TUCSON
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0AZ
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd085711
ReturnHeader/PreparerPersonGrp/PhoneNum05208863181
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0MICHAEL J DEVRIES
ReturnHeader/ReturnTs02021-05-11T17:49:46-05:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02019-07-01
ReturnHeader/TaxPeriodEndDt02020-06-30
ReturnHeader/TaxYr02019

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings